| __timestamp | Arrowhead Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 17763000 |
| Thursday, January 1, 2015 | 34718089 | 22180000 |
| Friday, January 1, 2016 | 40998209 | 37257000 |
| Sunday, January 1, 2017 | 32022880 | 27367000 |
| Monday, January 1, 2018 | 19110051 | 64770000 |
| Tuesday, January 1, 2019 | 26556257 | 74986000 |
| Wednesday, January 1, 2020 | 52275890 | 79256000 |
| Friday, January 1, 2021 | 80981000 | 100156000 |
| Saturday, January 1, 2022 | 124431000 | 131408000 |
| Sunday, January 1, 2023 | 90932000 | 152946000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing insights
In the competitive landscape of biotechnology, effective cost management is crucial. Arrowhead Pharmaceuticals, Inc. and Dynavax Technologies Corporation have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Arrowhead's SG&A expenses surged by approximately 300%, peaking in 2022. This reflects a strategic investment in growth and innovation. Meanwhile, Dynavax's expenses increased by nearly 760% during the same period, with a notable spike in 2023, indicating aggressive expansion efforts. However, data for 2024 is missing for Dynavax, suggesting potential reporting delays or strategic shifts. These trends highlight the dynamic nature of financial management in the biotech sector, where companies must balance operational costs with the pursuit of groundbreaking advancements.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Dynavax Technologies Corporation
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or BioCryst Pharmaceuticals, Inc.